<DOC>
	<DOC>NCT00961831</DOC>
	<brief_summary>This study is a visual assessment of diagnostic PET/CT images obtained after a single intravenous injection of BAY85-8050 in patients with cancer</brief_summary>
	<brief_title>Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and Patients</brief_title>
	<detailed_description />
	<criteria>Healthy volunteers only Males/females, &gt;/=50 and &lt;/= 65 years of age Cancer patients only Males/females &gt;/= 35 years and &lt;/= 75 years of age Patient had an FDG PET/CT for detection, or staging, or restaging, or therapy response assessment that still showed tumor mass Concurrent severe and/or uncontrolled and/or unstable other medical disease (e.g. poorly controlled diabetes, congestive heart failure, myocardial infarction within 12 months prior to planned injection of BAY858050, unstable and uncontrolled hypertension, chronic renal or hepatic disease, severe pulmonary disease) which could compromise participation in the study Known sensitivity to the study drug or components of the preparation</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Neoplasm</keyword>
	<keyword>PET/CT diagnosis</keyword>
	<keyword>PET tracer</keyword>
</DOC>